LOEWS CORP (L)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total | 4,555 | 4,494 | 4,466 | 4,267 |
| Operating expenses and other | - | - | 930 | 968 |
| Insurance claims and policyholders benefits (re-measurement loss of 15, 25, 23 and 40) | 2,085 | 2,027 | 2,019 | 1,882 |
| Interest | 107 | 105 | 114 | 114 |
| Equity method income | 18 | -1 | -9 | 27 |
| Amortization of deferred acquisition costs | 469 | 471 | 457 | 435 |
| Operating expenses and other | 989 | 991 | - | - |
| Non-insurance warranty expense | 384 | 385 | 387 | 388 |
| Total | 4,016 | 3,980 | 3,916 | 3,760 |
| Income before income tax | 539 | 514 | 550 | 507 |
| Income tax expense | 123 | 122 | 125 | 112 |
| Net income | 416 | 392 | 425 | 395 |
| Amounts attributable to noncontrolling interests | 25 | 22 | 24 | 26 |
| Net income attributable to loews corporation | 391 | 370 | 401 | 369 |
| Basic net income per share (in dollars per share) | 1.87 | 1.74 | 1.83 | 1.67 |
| Diluted net income per share (in dollars per share) | 1.87 | 1.74 | 1.82 | 1.67 |
| Shares of common stock (in shares) | 209,240,000 | 212,450,000 | 219,670,000 | 221,350,000 |
| Total weighted average shares outstanding assuming dilution (in shares) | 209,360,000 | 212,600,000 | 219,940,000 | 221,600,000 |